Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [How toxic and effective is simultaneous radiochemotherapy with hydroxyurea, 5-FU and cisplatin in cervix carcinoma?].

× No keyword cloud information.

10 in total

1. Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix.

Authors: E Rakovitch; A W Fyles; M Pintilie; P M Leung
Journal: Int J Radiat Oncol Biol Phys Date: 1997-07-15 Impact factor: 7.038

Review 2. Combined chemotherapy and radiation for locally advanced cervical carcinoma.

Authors: J Bridgewater
Journal: Clin Oncol (R Coll Radiol) Date: 1998 Impact factor: 4.126

3. Neoadjuvant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer.

Authors: P W Shueng; W L Hsu; Y M Jen; C J Wu; H S Liu
Journal: Int J Radiat Oncol Biol Phys Date: 1998-03-01 Impact factor: 7.038

4. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix.

Authors: C J Tseng; C T Chang; C H Lai; Y K Soong; J H Hong; S G Tang; S Hsueh
Journal: Gynecol Oncol Date: 1997-07 Impact factor: 5.482

5. Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer.

Authors: L C Wong; Y C Choo; D Choy; J S Sham; H K Ma
Journal: Gynecol Oncol Date: 1989-11 Impact factor: 5.482

6. Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer.

Authors: D R Christie; C A Bull; V Gebski; A O Langlands
Journal: Radiother Oncol Date: 1995-12 Impact factor: 6.280

Review 7. The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix.

Authors: S Wadler; G Goldberg; A Fields; P Anderson; J J Beitler; B Sood; H Haynes; C Runowicz
Journal: Semin Oncol Date: 1996-08 Impact factor: 4.929

8. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.

Authors: F B Stehman; B N Bundy; P R Kucera; G Deppe; S Reddy; D M O'Connor
Journal: Gynecol Oncol Date: 1997-08 Impact factor: 5.482

9. Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancer.

Authors: M S Piver; V Vongtama; L J Emrich
Journal: J Surg Oncol Date: 1987-06 Impact factor: 3.454

10. Concurrent 5-fluorouracil, daily low-dose cisplatin, and radiotherapy in stage IIIB cervical cancer. A phase II prospective study.

Authors: W L Hsu; P W Shueng; Y M Jen; C J Wu; H S Liu; C C Su; J M Hwang
Journal: Am J Clin Oncol Date: 1996-06 Impact factor: 2.339

10 in total